SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-000445
Filing Date
2023-01-05
Accepted
2023-01-05 09:26:55
Documents
16
Period of Report
2022-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42122
2 ex2-1.htm EX-2.1 393979
3 ex99-1.htm EX-99.1 124876
4 ex2-1_001.jpg GRAPHIC 19885
5 ex2-1_002.jpg GRAPHIC 21656
  Complete submission text file 0001493152-23-000445.txt   834221

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vynt-20221230.xsd EX-101.SCH 3227
7 XBRL LABEL FILE vynt-20221230_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE vynt-20221230_pre.xml EX-101.PRE 22359
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3701
Mailing Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002
Business Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002 201.528.9200
Vyant Bio, Inc. (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 23509890
SIC: 8071 Services-Medical Laboratories